CXCL12/CXCR4 signalling similarly regulates cell migration, proliferation, and survival pathways [42], with CXCR4 overexpression in primary BC is associated with high incidence of bone metastases by increasing BC cell homing to bone [20]. Here, CXCL12 is linked to breast cancer.